These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 34512957)
1. A primer on metabolic memory: why existing diabesity treatments fail. Copur S; Rossing P; Afsar B; Sag AA; Siriopol D; Kuwabara M; Ortiz A; Kanbay M Clin Kidney J; 2021 Mar; 14(3):756-767. PubMed ID: 34512957 [TBL] [Abstract][Full Text] [Related]
2. Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options. Potenza MA; Nacci C; De Salvia MA; Sgarra L; Collino M; Montagnani M Pharmacol Res; 2017 Jun; 120():226-241. PubMed ID: 28408314 [TBL] [Abstract][Full Text] [Related]
3. Drug treatments to restore vascular function and diabesity. Cardillo C Ann Pharm Fr; 2013 Jan; 71(1):27-33. PubMed ID: 23348853 [TBL] [Abstract][Full Text] [Related]
4. Adipokine Visfatin's Role in Pathogenesis of Diabesity and Related Metabolic Derangements. Kumari B; Yadav UCS Curr Mol Med; 2018; 18(2):116-125. PubMed ID: 29974830 [TBL] [Abstract][Full Text] [Related]
5. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Kato M; Natarajan R Nat Rev Nephrol; 2019 Jun; 15(6):327-345. PubMed ID: 30894700 [TBL] [Abstract][Full Text] [Related]
6. Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity. Villalobos-Labra R; Subiabre M; Toledo F; Pardo F; Sobrevia L Mol Aspects Med; 2019 Apr; 66():49-61. PubMed ID: 30472165 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic Mechanisms in Diabetic Kidney Disease. Thomas MC Curr Diab Rep; 2016 Mar; 16(3):31. PubMed ID: 26908156 [TBL] [Abstract][Full Text] [Related]
8. Medical Management of Diabesity: Do We Have Realistic Targets? Pappachan JM; Viswanath AK Curr Diab Rep; 2017 Jan; 17(1):4. PubMed ID: 28101792 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic Risk Profile of Diabetic Kidney Disease in High-Risk Populations. Xu L; Natarajan R; Chen Z Curr Diab Rep; 2019 Feb; 19(3):9. PubMed ID: 30730019 [TBL] [Abstract][Full Text] [Related]
10. Sex-specific epigenetic alterations of the hypothalamic Agrp-Pomc system do not explain 'diabesity' in the offspring of high-fat diet (HFD) overfed maternal rats. Schellong K; Melchior K; Ziska T; Henrich W; Rancourt RC; Plagemann A J Nutr Biochem; 2020 Jan; 75():108257. PubMed ID: 31710935 [TBL] [Abstract][Full Text] [Related]
15. Recent developments on the role of epigenetics in obesity and metabolic disease. van Dijk SJ; Tellam RL; Morrison JL; Muhlhausler BS; Molloy PL Clin Epigenetics; 2015; 7():66. PubMed ID: 27408648 [TBL] [Abstract][Full Text] [Related]
16. Study design and recruitment for a prospective controlled study of diabesity: Taiwan Diabesity Study. Lee WJ; Chang YC; Almalki O; Chao SH; Lu CH; Chen CC; Huang YY; Lee YC; Hsu CC Asian J Surg; 2019 Jan; 42(1):244-250. PubMed ID: 29631874 [TBL] [Abstract][Full Text] [Related]
17. Diabesity and brain disturbances: A metabolic perspective. Cardoso S; Moreira PI Mol Aspects Med; 2019 Apr; 66():71-79. PubMed ID: 30321556 [TBL] [Abstract][Full Text] [Related]
18. Diabesity: an overview of a rising epidemic. Farag YM; Gaballa MR Nephrol Dial Transplant; 2011 Jan; 26(1):28-35. PubMed ID: 21045078 [TBL] [Abstract][Full Text] [Related]